https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-to-Discontinue-IW-3718-Development-Program-Following-Results-from-Planned-Efficacy-Assessment/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- September 29, 2020